Journal Of Irreproducible Results

In the Oct. 2, 1995, issue of The Scientist on page 3, there was an article by Peter Gwynne ["Science Humor Magazine, Comic Awards Improbably Change Location"] concerning a conversation Gwynne had with Marc Abrahams. Some of the remarks and assertions made in this article have been repeated in other media, and it has become necessary to set the record straight concerning the relationship between the Journal of Irreproducible Results (JIR) and the Annals of Improbable Research (AIR). The article

Written byGeorge Scherr
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In order for Annals of Improbable Research to be the successor to the Journal of Irreproducible Results, it would be necessary for the JIR to no longer be published; otherwise, I fail to see how it can be a successor to it. JIR has been published for approximately 40 years on a continuous basis during the entire period of which, except for a short stint when it was published by Blackwell Scientific Publications, I have been the editor and publisher. The institution of the Ig Nobel prize and the awards made for such Ig Nobel research efforts was instituted by the JIR in the early 1970s and has continued under the aegis of JIR to this day. Neither Abrahams nor the AIR were ever associated with the Ig Nobel prize, nor was AIR even published until a few years ago.

Alex Kohn was the coeditor of the Journal of Irreproducible ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies